<DOC>
	<DOC>NCT00892918</DOC>
	<brief_summary>The purpose of this study is to determine whether there is a difference in corneal epithelial healing rate and/or toxicity following pterygium excision, between eyes treated post-operatively by moxifloxacin(VIGAMOX)versus gatifloxacin (ZYMAR).</brief_summary>
	<brief_title>Effect of Moxifloxacin Versus Gatifloxacin on Corneal Epithelium Following Pterygium Excision</brief_title>
	<detailed_description />
	<mesh_term>Pterygium</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>1. diagnosis of primary pterygium with a clinical indication for surgery 2. informed consent 1. known allergic reaction to fluoroquinolones. 2. secondary\recurrent pterygium or clinical suspected conjunctival tumor. 3. eye surgery in the last 6 months. 4. eye disorders: severe dry eye syndrome, ocular surface diseases, glaucoma, recurrent corneal erosions, chronic corneal diseases, after chemical burn. 5. low compliance. 6. pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>pterygium</keyword>
	<keyword>gatifloxacin</keyword>
	<keyword>moxifloxacin</keyword>
	<keyword>corneal epithelial defect</keyword>
</DOC>